ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 128 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $539,105 | +4.5% | 21,100 | +8.8% | 0.00% | -100.0% |
Q2 2023 | $515,652 | +12.1% | 19,400 | +16.2% | 0.00% | 0.0% |
Q1 2022 | $460,000 | -45.8% | 16,700 | -23.4% | 0.00% | 0.0% |
Q4 2021 | $848,000 | -52.4% | 21,800 | -52.5% | 0.00% | -66.7% |
Q1 2021 | $1,780,000 | -59.2% | 45,934 | -50.9% | 0.00% | -57.1% |
Q4 2020 | $4,368,000 | +106.6% | 93,534 | +89.1% | 0.01% | +40.0% |
Q3 2020 | $2,114,000 | -9.2% | 49,461 | -0.2% | 0.01% | -28.6% |
Q2 2020 | $2,328,000 | +1285.7% | 49,576 | +290.4% | 0.01% | +600.0% |
Q1 2020 | $168,000 | +24.4% | 12,700 | -2.3% | 0.00% | – |
Q4 2019 | $135,000 | – | 13,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DFPG INVESTMENTS, LLC | 183,803 | $9,359,000 | 5.00% |
DAFNA Capital Management LLC | 229,652 | $9,852,000 | 3.20% |
HealthCor Management, L.P. | 1,594,452 | $68,402,000 | 2.74% |
Capital Impact Advisors, LLC | 110,000 | $4,719,000 | 1.40% |
Cormorant Asset Management, LP | 700,000 | $30,030,000 | 1.16% |
ARK Investment Management | 2,495,842 | $107,072,000 | 0.64% |
Millrace Asset Group, Inc. | 18,087 | $776,000 | 0.63% |
COOPER CREEK PARTNERS MANAGEMENT LLC | 50,532 | $2,168,000 | 0.54% |
Endurant Capital Management LP | 34,485 | $1,479,000 | 0.44% |
HealthCor Management, L.P. | 200,000 | $8,580,000 | 0.34% |